Keenova Therapeutics plc Long-Lived Assets
Keenova Therapeutics plc had Long-Lived Assets of $403.00 million as of 2024-12-27, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2025-03-13
- 2024-12-27: Long-Lived Assets $403.00M.
- 2023-12-29: Long-Lived Assets $333.30M.
- 2022-12-30: Long-Lived Assets $468.40M.
- 2021-12-31: Long-Lived Assets $790.20M.
| Period end | Long-Lived Assets | Long-Lived Assets as first filed |
|---|---|---|
| 2024-12-27 | $403.00M 10-K · filed 2025-03-13 | |
| 2023-12-29 | $333.30M 10-K · filed 2025-03-13 | |
| 2022-12-30 | $468.40M 10-K · filed 2025-03-13 | |
| 2021-12-31 | $790.20M 10-K · filed 2023-03-03 | |
| 2020-12-25 | $846.40M 10-K · filed 2022-03-15 | |
| 2019-12-27 | $909.00M 10-K · filed 2021-03-10 | |
| 2018-12-28 | $994.20M 10-K · filed 2020-02-26 | |
| 2017-12-29 | $979.00M 10-K · filed 2019-02-26 | |
| 2016-12-30 | $893.50M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $856.10M 10-K · filed 2016-11-29 | |
| 2015-09-25 | $805.70M 10-K · filed 2016-11-29 | $994.70M 10-K · filed 2015-11-24 |
| 2014-09-26 | $904.00M 10-K · filed 2015-11-24 | $973.50M 10-K · filed 2014-11-25 |
| 2013-09-27 | $1.03B 8-K · filed 2015-04-03 | |
| 2012-09-28 | $972.00M 8-K · filed 2015-04-03 | |
| 2011-09-30 | $931.40M 10-K · filed 2013-12-13 |